Troluce Capital Advisors LLC bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 7,070 shares of the semiconductor company’s stock, valued at approximately $3,431,000. Synopsys comprises about 0.1% of Troluce Capital Advisors LLC’s portfolio, making the stock its 14th biggest holding.
Other institutional investors have also made changes to their positions in the company. Whipplewood Advisors LLC acquired a new position in Synopsys in the 4th quarter valued at $33,000. Pilgrim Partners Asia Pte Ltd acquired a new position in Synopsys in the 4th quarter valued at $34,000. Sierra Ocean LLC acquired a new position in Synopsys in the 4th quarter valued at $39,000. Hazlett Burt & Watson Inc. grew its holdings in Synopsys by 28.6% in the 4th quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company’s stock valued at $44,000 after buying an additional 20 shares in the last quarter. Finally, Annis Gardner Whiting Capital Advisors LLC grew its holdings in Synopsys by 50.8% in the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 98 shares of the semiconductor company’s stock valued at $48,000 after buying an additional 33 shares in the last quarter. 85.47% of the stock is owned by institutional investors and hedge funds.
Synopsys Stock Down 0.0%
Shares of SNPS stock opened at $514.43 on Friday. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $624.80. The company has a market cap of $79.54 billion, a P/E ratio of 35.43, a P/E/G ratio of 3.23 and a beta of 1.16. The business has a fifty day simple moving average of $444.44 and a 200 day simple moving average of $489.13.
Analysts Set New Price Targets
Read Our Latest Report on SNPS
Insider Buying and Selling
In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $463.75, for a total value of $5,270,982.50. Following the completion of the transaction, the chief executive officer now directly owns 70,922 shares in the company, valued at approximately $32,890,077.50. This trade represents a 13.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Geus Aart De sold 15,705 shares of the stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the completion of the transaction, the insider now owns 116,671 shares of the company’s stock, valued at $51,850,925.82. This represents a 11.86% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is owned by corporate insiders.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Savvy Investors Are Raising a Glass for Heineken Stock
- Business Services Stocks Investing
- Top 4 ETFs for China Exposure After Tariff Relief
- Financial Services Stocks Investing
- Build a Complete Bond Portfolio With These 4 ETFs
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.